| Financial Year |
March 31 2023 |
| Monetary Funds |
1,952,661,194.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,835,513.75 |
| Accounts Receivable |
279,623,265.03 |
| Advances to Suppliers |
1,132,577,076.83 |
| Other Receivables |
401,280,145.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,448,549,215.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
110,664,112.60 |
| Total Current Assets |
10,709,152,063.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
69,177,550.81 |
| Investment Properties |
39,847,444.35 |
| Fixed Assetes |
3,235,560,087.94 |
| Under-construction Projects |
318,671,115.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
279,860,390.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,489,950.38 |
| Deferred Income Tax Assets |
125,150,460.18 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,095,694,661.28 |
| Total Assets |
14,804,846,724.91 |
| Short-Term Loans |
5,077,248,769.09 |
| Trading Financial liabilities |
652,703,780.00 |
| Notes Payable |
79,829,948.25 |
| Accounts Payable |
886,291,949.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,450,948.15 |
| Taxes Payable |
141,902,780.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
106,913,103.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
603,830,047.96 |
| Other Current Liabilities |
215,395,525.84 |
| Sub-Total of Current Liabilities |
8,486,520,694.29 |
| Long-term Loans |
1,659,064,200.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,742,760.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,731,064.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,801,354,764.45 |
| Total Liabilities |
10,287,875,458.74 |
| Paid-In Capital(Or Share Stock) |
1,090,242,634.00 |
| Capital Surplus |
1,454,375,581.67 |
| Surplus Reserve |
278,920,567.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,664,500,528.99 |
| Minority Stockholder's Interest |
1,358,372.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,515,612,894.10 |
| Owner's Equity（Stockholder's Equity） |
4,516,971,266.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,804,846,724.91 |
